Show simple item record

dc.contributor.authorTirosh, Itay
dc.contributor.authorVenteicher, Andrew S.
dc.contributor.authorHebert, Christine
dc.contributor.authorEscalante, Leah E.
dc.contributor.authorPatel, Anoop P.
dc.contributor.authorYizhak, Keren
dc.contributor.authorFisher, Jonathan M.
dc.contributor.authorRodman, Christopher
dc.contributor.authorMount, Christopher
dc.contributor.authorFilbin, Mariella G.
dc.contributor.authorNeftel, Cyril
dc.contributor.authorDesai, Niyati
dc.contributor.authorNyman, Jackson
dc.contributor.authorIzar, Benjamin
dc.contributor.authorLuo, Christina C.
dc.contributor.authorFrancis, Joshua M.
dc.contributor.authorPatel, Aanand A.
dc.contributor.authorOnozato, Maristela L.
dc.contributor.authorRiggi, Nicolo
dc.contributor.authorLivak, Kenneth J.
dc.contributor.authorGennert, Dave
dc.contributor.authorSatija, Rahul
dc.contributor.authorNahed, Brian V.
dc.contributor.authorCurry, William T.
dc.contributor.authorMartuza, Robert L.
dc.contributor.authorMylvaganam, Ravindra
dc.contributor.authorIafrate, A. John
dc.contributor.authorFrosch, Matthew P.
dc.contributor.authorRivera, Miguel N.
dc.contributor.authorGetz, Gad
dc.contributor.authorRozenblatt-Rosen, Orit
dc.contributor.authorCahill, Daniel P.
dc.contributor.authorMonje, Michelle
dc.contributor.authorBernstein, Bradley E.
dc.contributor.authorLouis, David N.
dc.contributor.authorSuvà, Mario L.
dc.contributor.authorGolub, Todd
dc.contributor.authorRegev, Aviv
dc.date.accessioned2018-07-03T14:38:08Z
dc.date.available2018-07-03T14:38:08Z
dc.date.issued2016-11
dc.date.submitted2016-05
dc.identifier.issn0028-0836
dc.identifier.issn1476-4687
dc.identifier.urihttp://hdl.handle.net/1721.1/116752
dc.description.abstractAlthough human tumours are shaped by the genetic evolution of cancer cells, evidence also suggests that they display hierarchies related to developmental pathways and epigenetic programs in which cancer stem cells (CSCs) can drive tumour growth and give rise to differentiated progeny. Yet, unbiased evidence for CSCs in solid human malignancies remains elusive. Here we profile 4,347 single cells from six IDH1 or IDH2 mutant human oligodendrogliomas by RNA sequencing (RNA-seq) and reconstruct their developmental programs from genome-wide expression signatures. We infer that most cancer cells are differentiated along two specialized glial programs, whereas a rare subpopulation of cells is undifferentiated and associated with a neural stem cell expression program. Cells with expression signatures for proliferation are highly enriched in this rare subpopulation, consistent with a model in which CSCs are primarily responsible for fuelling the growth of oligodendroglioma in humans. Analysis of copy number variation (CNV) shows that distinct CNV sub-clones within tumours display similar cellular hierarchies, suggesting that the architecture of oligodendroglioma is primarily dictated by developmental programs. Subclonal point mutation analysis supports a similar model, although a full phylogenetic tree would be required to definitively determine the effect of genetic evolution on the inferred hierarchies. Our single-cell analyses provide insight into the cellular architecture of oligodendrogliomas at single-cell resolution and support the cancer stem cell model, with substantial implications for disease management.en_US
dc.publisherNature Publishing Groupen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/NATURE20123en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titleSingle-cell RNA-seq supports a developmental hierarchy in human oligodendrogliomaen_US
dc.typeArticleen_US
dc.identifier.citationTirosh, Itay et al. “Single-Cell RNA-Seq Supports a Developmental Hierarchy in Human Oligodendroglioma.” Nature 539, 7628 (November 2016): 309–313 © 2016 Macmillan Publishers Limited, part of Springer Natureen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorGolub, Todd
dc.contributor.mitauthorRegev, Aviv
dc.relation.journalNatureen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-07-03T13:02:04Z
dspace.orderedauthorsTirosh, Itay; Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E.; Patel, Anoop P.; Yizhak, Keren; Fisher, Jonathan M.; Rodman, Christopher; Mount, Christopher; Filbin, Mariella G.; Neftel, Cyril; Desai, Niyati; Nyman, Jackson; Izar, Benjamin; Luo, Christina C.; Francis, Joshua M.; Patel, Aanand A.; Onozato, Maristela L.; Riggi, Nicolo; Livak, Kenneth J.; Gennert, Dave; Satija, Rahul; Nahed, Brian V.; Curry, William T.; Martuza, Robert L.; Mylvaganam, Ravindra; Iafrate, A. John; Frosch, Matthew P.; Golub, Todd R.; Rivera, Miguel N.; Getz, Gad; Rozenblatt-Rosen, Orit; Cahill, Daniel P.; Monje, Michelle; Bernstein, Bradley E.; Louis, David N.; Regev, Aviv; Suvà, Mario L.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-8567-2049
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record